Fertility Clinics in the US Industry Market Research Report from IBISWorld Has Been Updated
New York, NY (PRWEB) March 04, 2015 -- In the five years to 2015, revenue for the Fertility Clinics industry is expected to increase moderately. Although the industry weathered the recession fairly well, the decline in per capita disposable income and drop in the number of people with private health insurance slowed the industry's growth and caused revenue to remain constrained early in the five-year period. According to IBISWorld Industry Analyst Lucas Isakowitz, “In 2015, continued improvement in the labor market is expected to boost per capita disposable income and increase the number of people with private health insurance, increasing demand for fertility clinics; consequently, revenue is anticipated to increase slowly in 2015.”
Over the past decade, infertility treatments have become more advanced and less risky, resulting in an increasing number of women, especially over the age of 40, seeking industry services. In the five years to 2012 (latest data available), the number of in vitro fertilization (IVF) procedures has increased moderately. According to the Center for Disease Control's Assisted Reproductive Technology (ART) Report, the percentage of pregnancy success rates is greater when using frozen embryos, rather than fresh ones, in women older than 35. Consequently, in 2012 (latest data available) the number of frozen embryo transfers made up 28.2% of all treatments, significantly higher than their portion in 2009 (19.0% of all treatments). This trend is anticipated to continue, with infertility treatments continuing to evolve, encouraging more individuals and couples to seek industry services.
Most fertility centers are small clinics that service a local population. As a result, just one company (IntegraMed America) has a substantial market share and the industry has a low market share concentration. Fertility Clinics industry concentration is expected to remain low during the five years to 2020.
Industry revenue is anticipated to continue grow in the five years to 2020. “Declining unemployment and increasing corporate profit will ultimately boost per capita disposable income and the number of people with private health insurance, allowing more individuals to afford industry services, says Isakowitz. Additionally, the 2010 healthcare reform will increase access to public health insurance, which often covers some degree of infertility treatment, further raising demand for industry services.
For more information, visit IBISWorld’s Fertility Clinics in the US industry report page.
Follow IBISWorld on Twitter: https://twitter.com/#!/IBISWorld
Friend IBISWorld on Facebook: http://www.facebook.com/pages/IBISWorld/121347533189
IBISWorld industry Report Key Topics
This industry includes medical facilities that offer treatments to aid individuals in conceiving children. These facilities offer diagnosis, medications, intrauterine insemination, in vitro fertilization and other assisted reproductive technology methods.
Industry Performance
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
Products & Markets
Supply Chain
Products & Services
Major Markets
Globalization & Trade
Business Locations
Competitive Landscape
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Barriers to Entry
Major Companies
Operating Conditions
Capital Intensity
Key Statistics
Industry Data
Annual Change
Key Ratios
About IBISWorld Inc.
Recognized as the nation’s most trusted independent source of industry and market research, IBISWorld offers a comprehensive database of unique information and analysis on every US industry. With an extensive online portfolio, valued for its depth and scope, the company equips clients with the insight necessary to make better business decisions. Headquartered in Los Angeles, IBISWorld serves a range of business, professional service and government organizations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.com or call 1-800-330-3772.
Gavin Smith, IBISWorld, +1 (310) 866-5042, [email protected]
Share this article